-
Mashup Score: 13
In men with prostate-specific membrane antigen–defined, oligorecurrent M1a–b prostate cancer, short-course androgen annihilation therapy and metastasis-directed stereotactic body radiotherapy achieved a substantial disease-free interval following testosterone recovery. This regimen was well tolerated, and 90% of patients completed therapy with androgen deprivation therapy and at least one androgen receptor pathway inhibitor.
Source: www.europeanurology.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Small-cell bladder cancer (SCBC) is a highly aggressive malignancy representing the commonest subtype of bladder tumor with neuroendocrine (NE) features [1]. SCBC is a rare entity among divergent histologies and it has been historically associated with small-cell tumors arising in other solid organs owing to shared histological and immunohistochemical features [2]. Therapeutic management of SCBC has been mainly extrapolated from results obtained in small-cell lung cancer (SCLC), the most prevalent small-cell malignancy.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 52
Findings from this first randomised trial comparing robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion to open RC confirm that it is a safe surgical option. The transfusion rate was 50% lower, while complication rates and 3-yr oncological outcomes were comparable to those for open RC. The probabilities of daytime and night-time continence recovery were comparable between groups, while scores for body image were higher after RARC. Higher costs remain a drawback of robotic surgery.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 14Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study - 4 day(s) ago
The use of prophylactic implantation of a lightweight mesh in the sublay position decreases the risk of parastomal hernia after radical cystectomy and urinary diversion with an ileal conduit without causing any mesh-related complications, although with prolonged operating time.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 79Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology - 5 day(s) ago
The updated 2024 European Association of Urology neurourology guidelines highlight the importance of a tailored, comprehensive approach for management of neurourological disorders. Patient outcomes can be improved by addressing individual needs, including urodynamics and lifestyle considerations via a multidisciplinary strategy. The guidelines cover the latest evidence and treatments to support patients in maintaining their quality of life across all facets of neurological impact.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 23Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis - 6 day(s) ago
Using thulium fiber laser rather than holmium:yttrium aluminum garnet laser may achieve higher stone-free rates in stones located in the kidney but not in the ureter.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet-
Thulium Fiber Laser Versus Holmium: Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis Full article: https://t.co/XHc3FnG4hP @Aleuleri @FarreAlf @pizquierdog @JBalana_ @D_Castellani @endourologyucsd @MantuGuptaMD @agallioli @AlbertoBreda1 @emiliani_e https://t.co/NN7PC3yvfE
-
-
Mashup Score: 3Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer - 7 day(s) ago
We show that longer exposure to 177Lu-PSMA-617 treatment for up to six cycles was not associated with greater toxicity risk. Safety analyses support a favourable benefit-risk profile for six cycles of 177Lu-PSMA-617 in patients with progressive, prostate-specific membrane antigen–positive, metastatic castration-resistant prostate cancer.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4Robot-assisted Kidney Transplantation: The European Experience - 11 day(s) ago
Surgical data show that robot-assisted kidney transplantation is safe, feasible, and reproducible when performed by surgeons with experience in both robotic and kidney transplantation surgery. Furthermore, use of a robotic technique yields low complication rates in selected cases while maintaining excellent graft function.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 87
After rigorous adjustment, radical prostatectomy was associated with a lower risk of prostate cancer–specific and overall mortality, especially in patients with higher-risk disease, in comparison to other treatments according to data from a large, prospective, multicenter, community-based cohort of men with localized prostate cancer.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 43
Use of prostate-specific membrane antigen positron emission tomography to determine disease extent provides a novel method for risk stratification for patients with nonmetastatic castration-resistant prostate cancer and may contribute to future risk-adapted treatment algorithms.
Source: www.europeanurology.comCategories: General Medicine News, UrologyTweet
‼️SBRT+6 mo systemic therapy decreased the recurrence rates in oligorecurrent metastatic prostate cancer! (A phase 2 trial) 🔔 At 6 months after testosterone recovery 50% of all pts were still responder! @OncoAlert @EurUrolOncol @DanaFarber_GU https://t.co/KRry5FOYbo